查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1557252

全球嬰兒奶粉市場 - 2024 年至 2029 年預測

Global Infant Formula Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 149 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

嬰兒奶粉市場預計到 2029 年將達到 842.68 億美元，預測期內複合年成長率為 5.60%，較 2024 年的 641.83 億美元成長。

嬰兒奶粉，或稱為嬰兒配方奶粉，是專門為一歲以下嬰兒提供營養和維生素的配方奶粉。這些配方奶粉可以幫助嬰兒緩解胃食道逆流，也可以幫助新生兒增加體重。它還可以給予早產兒和低出生體重兒，為他們提供發育所需的基本補充品、礦物質和熱量。

根據評估，增加女性就業和增加女性在全球勞動力中的參與度將推動嬰兒奶粉市場的發展。預計女性加入勞動市場將增加可支配收入，並進一步減少全球市場參與企業的母乳哺育。根據世界銀行的訊息，過去兩年，全球女性勞動力比例已從2022年的39.7%擴大到2023年的約40.1%。資料進一步顯示，在日本和美國等國家，女性勞動參與率將從2022年的44.9%和46.3%分別擴大到2023年的45.1%和46.5%。

嬰兒奶粉市場促進因素

  • 世界人口的持續成長預計將推動嬰兒奶粉的需求。

預計推動全球嬰兒奶粉需求的關鍵促進因素之一是世界人口的持續成長。隨著這一成長，世界各地出生的嬰兒數量也將增加。全球人口的成長和出生人數的增加預計將在預測期內推動全球對嬰兒奶粉的需求。

根據世界銀行的報告，世界人口將從 2022 年的 79.5 億增加到 2023 年的 80.2 億。這代表著世界人口的穩定成長，特別是在印度、馬來西亞和越南等開發中國家。印度是世界上人口最多的國家，到 2023 年，該國人口居住約 14.3 億。人口的不斷成長將迅速增加嬰兒食品和嬰兒奶粉的市場需求。

嬰幼兒奶粉市場區隔分析

  • 基於牛奶蛋白的嬰兒奶粉預計將推動市場擴張。

消費者日益認知到牛奶蛋白開拓嬰兒一般市場提供健康和營養的益處，從而推動了基於牛奶蛋白的嬰兒奶粉市場的發展。小兒科廣泛推薦以牛奶蛋白為基礎的嬰兒奶粉作為母乳的替代品。推動這一領域發展的關鍵因素之一是嬰兒奶粉比其他類型的配方奶粉具有多種健康益處。

這種奶粉含有比牛蛋白更多的乳清，更容易消化，適合新生兒。從出生到一歲都可以使用。因此，母親們不需要改變配方奶粉，從而推動了這一領域的成長。大多數醫生都會開立以牛奶為基礎的嬰兒奶粉，因為這種配方奶粉中的蛋白質與母乳中的蛋白質相似。

此外，不斷上升的嬰兒死亡率也是該國需要營養奶粉的原因之一。例如，根據美國疾病管制與預防中心的數據，2022年美國新生兒死亡率為每1,000名活產兒5.60例，比2021年每1,000例活產兒5.44例增加3%。預計新生兒死亡率的上升將是在預期期內加強牛奶蛋白嬰兒配方奶粉市場的關鍵因素之一。

主要市場參與企業和新參與企業正在投資於產品發布、市場開拓和合作夥伴關係等關鍵市場活動，以滿足對基於牛奶蛋白的嬰兒配方奶粉奶粉日益成長的需求。

預計美國地區將對市場成長做出重大貢獻。

美國對有機嬰兒配方奶粉的需求預計將會增加。父母對應該購買哪種營養補充劑的認知不斷提高，是預測期內有機嬰兒配方奶粉需求成長的關鍵原因之一。此外，全國對嬰兒奶粉的需求預計將增加。這些特殊奶粉含有特殊成分，如水解蛋白、胺基酸和益生元。

此外，該公司正在增加對美國嬰兒奶粉市場的投資，預計這將推動未來幾年的市場成長。例如，2022 年 3 月，美國首批生產有機嬰兒奶粉的公司之一 Bobbi 宣布完成 5,000 萬美元資金籌措。這也包括由 ParkWest 以及現有投資者 Nextview 和 VMG主導的B 輪資金籌措。這筆資金籌措將使該公司能夠加快嬰兒奶粉的生產，並支持對營養配方奶粉不斷成長的需求。因此，這種增加的投資預計將推動市場成長。

根據美國商務部統計，2023年美國嬰幼兒（0-5歲）總數為18,511,160人。其中，男性 9,459,399 人，女性 9,051,761 人。目前，根據世界銀行的數據，0 至 14 歲的幼兒占美國人口的 18%。因此，隨著嬰兒人口的增加，預計未來幾年對嬰兒奶粉的需求將會成長。

嬰兒奶粉主要市場開拓：

  • 2022 年 12 月 - 雅培營養宣佈在俄亥俄州鮑靈格林建立新的嬰兒配方奶粉生產工廠。該公司計劃投資 5 億美元建造該工廠，並在俄亥俄州西北部地區創造 450 個永久性就業機會。該設施預計將於 2026 年竣工，並於 2027 年開始商業生產。
  • 2022 年 3 月——總部位於紐約、致力於創造新生兒營養新標準的下一代嬰兒營養公司 ByHeart 推出了期待已久的奶粉，以更好地為嬰兒和父母服務。此配方奶含有有機草飼全脂牛奶和母乳中最豐富的兩種蛋白質的獨特混合物。

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行摘要

  • 主要發現

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第5章全球嬰兒奶粉市場：依配方奶粉類型

  • 介紹
  • 牛奶蛋白基質
  • 以大豆為基礎
  • 蛋白質水解物

第6章 全球嬰兒奶粉市場：依形式分類

  • 介紹
  • 粉末
  • 濃縮液
  • 準備使用

第7章 全球嬰兒奶粉市場：依通路分類

  • 介紹
  • 離線
  • 線上

第8章全球嬰兒奶粉市場：按地區

  • 介紹
  • 北美洲
    • 依公式類型
    • 按形式
    • 按分銷管道
    • 按國家/地區
  • 南美洲
    • 依公式類型
    • 按形式
    • 按分銷管道
    • 按國家/地區
  • 歐洲
    • 依公式類型
    • 按形式
    • 按分銷管道
    • 按國家/地區
  • 中東/非洲
    • 依公式類型
    • 按形式
    • 按分銷管道
    • 按國家/地區
  • 亞太地區
    • 依公式類型
    • 按形式
    • 按分銷管道
    • 按國家/地區

第9章競爭環境及分析

  • 主要企業及策略分析
  • 新興參與企業和巨大的盈利
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第10章 公司簡介

  • Abbott
  • Nestle SA
  • Dana Dairy Group
  • Danone
  • Ausnutria Dairy Corporation Ltd.
  • Perrigo Company plc
  • Else Nutrition
  • Biostime
  • HHPL Healthcare
  • Mead Johnson & Company, LLC
  • Estrellas Life Sciences Pvt Ltd
  • Nutricore Biosciences Pvt. Ltd.
  • Morinaga Milk Industry Co.,Ltd.
  • Meiji Holdings Co., Ltd.
  • Bean Stalk Snow Co.,Ltd
簡介目錄
Product Code: KSI061613040

The global infant formula market is projected to grow at a CAGR of 5.60% over the forecast period, from US$64.183 billion in 2024, and is expected to reach US$84.268 billion by 2029.

Infant formula or baby formula is a process specially designed to provide nutrition and vitamins to infants, especially those under the age of one year. These formulas help babies with reflux issues and additionally offer assistance with newborn children's weight gain. It can also be fed to premature and low-birth-weight babies because it gives them fundamental supplements, minerals, and calories to develop.

The increment in female employment or growing female participation within the worldwide workforce is evaluated to push the market for infant formula forward. The increment in female participation within the workforce is forecasted to boost disposable income and is additionally evaluated to decrease breastfeeding of infants within the worldwide market. Within the past two years, the worldwide female labor force expanded from 39.7% in 2022 to almost 40.1% in 2023, according to the World Bank information. The data further expressed that in countries like Japan and the USA, female workforce participation expanded from 44.9% and 46.3% in 2022 to 45.1% and 46.5%, respectively, in 2023.

GLOBAL INFANT FORMULA MARKET DRIVERS:

  • The constantly growing global population is expected to boost the demand for infant formula.

One of the major driving variables anticipated to push the worldwide demand for infant formula is the continually growing global population. With this increment, the number of children born worldwide will increase. This increment in the worldwide population and increasing childbirth are anticipated to boost the worldwide demand for infant formula in the forecasted period.

The World Bank observed in its report that the global population reached 8.02 billion in 2023, up from 7.95 billion in 2022. This represents a steady rise in the worldwide population, particularly in developing countries such as India, Malaysia, and Vietnam. India is home to the biggest population globally, with around 1.43 billion individuals living within the country in 2023. The expanding population surges the market's requirement for infant food and formula.

GLOBAL INFANT FORMULA MARKET SEGMENT ANALYSIS

  • The cow's milk protein-based infant formula is anticipated to boost the market expansion.

The infant formula market for cow's milk protein-based is driven by expanding consumer mindfulness of the healthy and nutritious benefits of cow milk protein for general infant development. Pediatricians broadly endorse cow milk protein-based infant formulas as an elective to breast milk. One of the primary variables driving this segment's development is the various well-being benefits of cow milk infant formula over other types of infant formula.

This type of formula contains more bovine whey than casein, making it simpler to digest, which makes it more suited to newborns. It is suitable from birth until the child turns one. Therefore, mothers don't need to change the formula driving this segment's growth. Most doctors prescribe cow milk-based infant formula as the protein found in this formula is similar to breast milk proteins.

Moreover, the expanding infant mortality rate is one of the reasons for the need for nutritious infant formula within the nation. For instance, according to the Centers for Disease Control and Prevention, the infant mortality rate within the United States in 2022 was 5.60 per 1,000 live births, which was 3% higher compared to 2021, where the infant mortality rate was 5.44 per 1,000 live births. The increase in cases of newborn mortality is expected to be one of the major reasons for the bolstering of the market for cow milk protein-based infant formula within the anticipated period.

Key market players and new entrants are investing in major market activities such as product launches, developments, and collaborations to meet the growing demand for cow milk protein-based infant formula products.

The United States region is predicted to contribute significantly to market growth.

The demand for organic infant formula is anticipated to rise in the United States. Rising awareness among guardians about the kind of nutrition to purchase is one of the major reasons for the expanding request for organic infant formula within the forecasted period. Moreover, the demand for specialty infant formula is expected to increase nationwide. These specialty formulas have specialized ingredients such as hydrolyzed protein, amino acids, and prebiotics.

Furthermore, companies are increasing their investments in the United States infant formula market, which is expected to drive market growth in the coming years. For instance, in March 2022, Bobbie, one of the first organic infant formula companies manufacturing in the United States, announced that it had closed funding to US$50 million. This included its Series B funding, which was led by Park West, with existing investors Nextview and VMG. This funding will help the company accelerate the production of its infant formula and support the growing demand for nutritious formula. Hence, such rising investments are expected to fuel the market growth.

According to the U.S. Department of Commerce, the total number of infants (0-5 years) in the United States in 2023 was 1,85,11,160. Of this, 94,59,399 were males, and 90,51,761 were females. Currently, according to the World Bank, 18% of the United States population comprises children aged 0-14 years. Hence, in the coming years, with the rising infant population, the demand for infant formula is anticipated to grow.

Global Infant Formula Key Market Developments:

  • December 2022 - Abbott Nutrition unveiled a new formula production facility in Bowling Green, Ohio. The company plans to invest US$500 million in this facility and to create 450 permanent jobs in the northwest Ohio region. The facility construction is expected to be over by 2026, and commercial production is anticipated to start by 2027.
  • March 2022 - ByHeart, a New York-based next-generation baby nutrition company devoted to creating a new standard for newborn nutrition, introduced its much-anticipated cow milk infant formula to better serve babies and parents. The formula contains organic, grass-fed whole milk and a proprietary mix of the two most prevalent proteins in breast milk.

Market Segmentation:

Global Infant Formula Market is segmented and analyzed as below:

By Formula Type

  • Cow's Milk Protein-Based
  • Soy-Based
  • Protein Hydrolysate

By Form

  • Powdered
  • Concentrated Liquid
  • Ready-to-Use

By Distribution Channel

  • Offline
  • Online

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst view

5. GLOBAL INFANT FORMULA MARKET BY FORMULA TYPE

  • 5.1. Introduction
  • 5.2. Cow's Milk Protein-Based
  • 5.3. Soy-Based
  • 5.4. Protein Hydrolysate

6. GLOBAL INFANT FORMULA MARKET BY FORM

  • 6.1. Introduction
  • 6.2. Powdered
  • 6.3. Concentrated Liquid
  • 6.4. Ready-to-Use

7. GLOBAL INFANT FORMULA MARKET BY DISTRIBUTION CHANNEL

  • 7.1. Introduction
  • 7.2. Offline
  • 7.3. Online

8. GLOBAL INFANT FORMULA MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Formula Type
    • 8.2.2. By Form
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Formula Type
    • 8.3.2. By Form
    • 8.3.3. By Distribution Channel
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Formula Type
    • 8.4.2. By Form
    • 8.4.3. By Distribution Channel
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Italy
      • 8.4.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Formula Type
    • 8.5.2. By Form
    • 8.5.3. By Distribution Channel
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Formula Type
    • 8.6.2. By Form
    • 8.6.3. By Distribution Channel
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Thailand
      • 8.6.4.7. Indonesia
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Emerging Players and Markey Lucrativeness
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Abbott
  • 10.2. Nestle S.A.
  • 10.3. Dana Dairy Group
  • 10.4. Danone
  • 10.5. Ausnutria Dairy Corporation Ltd.
  • 10.6. Perrigo Company plc
  • 10.7. Else Nutrition
  • 10.8. Biostime
  • 10.9. HHPL Healthcare
  • 10.10. Mead Johnson & Company, LLC
  • 10.11. Estrellas Life Sciences Pvt Ltd
  • 10.12. Nutricore Biosciences Pvt. Ltd.
  • 10.13. Morinaga Milk Industry Co.,Ltd.
  • 10.14. Meiji Holdings Co., Ltd.
  • 10.15. Bean Stalk Snow Co.,Ltd